Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study-Reference-Cited by-同舟云学术

Intravitreal Aflibercept Injection for Macular Edema Secondary to Central Retinal Vein Occlusion: 1-Year Results From the Phase 3 COPERNICUS Study

Published:2013-03 Issue:3 Volume:155 Page:429-437.e7
ISSN:0002-9394
Container-title:American Journal of Ophthalmology
language:en
Short-container-title:American Journal of Ophthalmology

Author:

Brown David M.,Heier Jeffrey S.,Clark W. Lloyd,Boyer David S.,Vitti Robert,Berliner Alyson J.,Zeitz Oliver,Sandbrink Rupert,Zhu Xiaoping,Haller Julia A.

Publisher

Elsevier BV

Subject

Ophthalmology

Reference17 articles.

1. Intravitreal triamcinolone acetonide as treatment of macular edema in central retinal vein occlusion;Jonas;Graefes Arch Clin Exp Ophthalmol,2002

2. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion;Ding;Retina,2011

3. Baseline predictors of visual acuity and retinal thickness outcomes in patients with retinal vein occlusion: Standard Care Versus COrticosteroid for REtinal Vein Occlusion Study report 10;Scott;Ophthalmology,2011

4. SCORE Study report 1: baseline associations between central retinal thickness and visual acuity in patients with retinal vein occlusion;Scott;Ophthalmology,2009

5. Ranibizumab for macular edema due to retinal vein occlusions: long-term follow-up in the HORIZON trial;Heier;Ophthalmology,2012

Cited by 305 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Integrated Assessment of OCT, Multimodal Imaging, and Cytokine Markers for Predicting Treatment Responses in Retinal Vein Occlusion Associated Macular Edema: A Comparative Review of Anti-VEGF and Steroid Therapies;Diagnostics;2024-09-07

2. Evaluation of Anatomical and Tomographic Biomarkers as Predictive Visual Acuity Factors in Eyes with Retinal Vein Occlusion Treated with Dexamethasone Implant;Journal of Clinical Medicine;2024-08-02

3. Time to initiate anti-vascular endothelial growth factor therapy and visual outcome in central retinal vein occlusion;Scientific Reports;2024-07-23

4. Retinal Vein Occlusion–Background Knowledge and Foreground Knowledge Prospects—A Review;Journal of Clinical Medicine;2024-07-05

5. Disparities in Retinal Vein Occlusion Presentation and Initiation of Anti-VEGF Therapy;Ophthalmology Retina;2024-07